| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 209026 |
cas:6974-32-9 1-乙酰氧基-2,3,5-三苯甲酰氧基-1-β-D-呋喃核糖 |
403 |
zyl |
2023-11-16 |
| 209027 |
PROTAC STING Degrader-1 蛋白水解靶向嵌合体 |
533 |
wff |
2023-11-16 |
| 209028 |
cas:84297-22-3 1-萘基-Β-D-甘露糖苷 1-naphthyl-b-d-mannose的密度 |
338 |
zyl |
2023-11-16 |
| 209029 |
CP-10 PROteolysis-TArgeting Chimeras 技术 |
318 |
wff |
2023-11-16 |
| 209030 |
PROTAC RIPK degrader-6 小分子抑制剂 |
343 |
wff |
2023-11-16 |
| 209031 |
16:0 2-PC 1,3-二棕榈酰rac-甘油-2-磷酸胆碱 1,3-dipalmitoyl-rac-glycero-2-phosphocholine |
314 |
LYQ |
2023-11-16 |
| 209032 |
11:0 PC 27869-47-2 L-α-磷脂酰胆碱 |
334 |
LYQ |
2023-11-16 |
| 209033 |
PCL-PEG-Pemetrexed,聚己内酯-聚乙二醇-培美曲塞 |
318 |
lcy |
2023-11-16 |
| 209034 |
PCL-PEG-Raltitrexed,聚己内酯-聚乙二醇-雷替曲塞 |
347 |
lcy |
2023-11-16 |
| 209035 |
PCL-PEG-Metronidazole,聚己内酯-聚乙二醇-甲硝唑 |
313 |
lcy |
2023-11-16 |
| 209036 |
10:0 PC 3436-44-0 二癸酰基卵磷脂 |
302 |
LYQ |
2023-11-16 |
| 209037 |
PCL-PEG-Ferrocene,聚己内酯-聚乙二醇-二茂铁 |
279 |
lcy |
2023-11-16 |
| 209038 |
09:0 PC 27869-45-0 1,2-二壬酰-Sn-甘油-3-磷酰胆碱 |
440 |
LYQ |
2023-11-16 |
| 209039 |
PCL-PEG-Dopamine,聚己内酯-聚乙二醇-多巴胺 |
298 |
lcy |
2023-11-16 |
| 209040 |
PCL-PEG-R8,聚己内酯-聚乙二醇-R8,纯度≥95%,溶于大部分有机溶剂 |
374 |
lcy |
2023-11-16 |
| 209041 |
Azide-PEG4-Br，CAS1951439-37-4，溴代四聚乙二醇叠氮，分子量326.19 |
300 |
axc |
2023-11-16 |
| 209042 |
PCL-PEG-MMPs,聚己内酯-聚乙二醇-MMPs,溶于大部分有机溶剂 |
302 |
lcy |
2023-11-16 |
| 209043 |
Azide-PEG3-Br，CAS1446282-43-4，溴代三聚乙二醇叠氮，分子量282.14 |
334 |
axc |
2023-11-16 |
| 209044 |
Azide-PEG7-OTs，CAS1418561-41-7，叠氮七聚乙二醇对甲苯磺酸酯，分子量505.58 |
346 |
axc |
2023-11-16 |
| 209045 |
PCL-PEG-WSW,聚己内酯-聚乙二醇-WSW |
317 |
lcy |
2023-11-16 |
| 209046 |
Azide-PEG5-OTs，CAS236754-49-7，叠氮五聚乙二醇对甲苯磺酸酯，分子量: 417.48 |
327 |
axc |
2023-11-16 |
| 209047 |
azido-PEG10-OH，cas:73342-16-2，叠氮-PEG10-羟基，分子量：571.65876 |
323 |
axc |
2023-11-16 |
| 209048 |
PCL-PEG-YIGSR,聚己内酯-聚乙二醇-YIGSR |
315 |
lcy |
2023-11-16 |
| 209049 |
PCL-PEG-CCK8,聚己内酯-聚乙二醇-生物活性CCK8肽 |
332 |
lcy |
2023-11-16 |
| 209050 |
azido-PEG5-OH，cas:86770-68-5，叠氮-PEG5-羟基，分子量：263.29 |
285 |
axc |
2023-11-16 |
| 209051 |
PCL-PEG-Octreotide,聚己内酯-聚乙二醇-奥曲肽,纯度≥95% |
299 |
lcy |
2023-11-16 |
| 209052 |
PCL-PEG-CDDP,聚己内酯-聚乙二醇-顺铂,纯度≥95% |
288 |
lcy |
2023-11-16 |
| 209053 |
PCL-PEG-DOX 聚己内酯-聚乙二醇-阿霉素 |
317 |
lcy |
2023-11-16 |
| 209054 |
PCL-PEG-Dextran,聚己内酯-聚乙二醇-葡聚糖 |
300 |
lcy |
2023-11-16 |
| 209055 |
Azido-PEG2-PFP ester，CAS: 1393330-37-4，叠氮-PEG2-PFP酯，分子量：369.3 |
318 |
axc |
2023-11-16 |
| 209056 |
N3-tetra-EGOPFP 抗体-药物偶联物 |
323 |
wff |
2023-11-16 |
| 209057 |
Azido-PEG8-TFP ester，cas:1818294-49-3，分子量：615.58 |
312 |
axc |
2023-11-16 |
| 209058 |
PY-DS-DMBUT-OPFP 2101206-44-2 |
316 |
wff |
2023-11-16 |
| 209059 |
Phe-Lys(Trt)-PAB 1116085-99-4 |
272 |
wff |
2023-11-16 |
| 209060 |
Fmoc-Val-Cit-PAB 159858-22-7 |
400 |
wff |
2023-11-16 |
| 209061 |
Azido-PEG4-TFP ester，cas:1807505-33-4，分子量：439.36 |
340 |
axc |
2023-11-16 |
| 209062 |
PCL-PEG-ConA,聚己内酯-聚乙二醇-刀豆球蛋白A |
292 |
lcy |
2023-11-16 |
| 209063 |
VAL-CIT-PAB 159857-79-1 用途：科研 状态：固体/粉末/溶液 |
322 |
wff |
2023-11-16 |
| 209064 |
Ala-Ala-Asn-PAB 2149584-00-7 |
357 |
wff |
2023-11-16 |
| 209065 |
PCL-PEG-DMG,聚己内酯-聚乙二醇-二肉豆蔻酰-sn-甘油 |
332 |
lcy |
2023-11-16 |
| 209066 |
Mc-Val-Cit-PABC-PNP 159857-81-5 |
360 |
wff |
2023-11-16 |
| 209067 |
Fmoc-Gly3-Val-Cit-PAB-PNP 2647914-16-5 |
336 |
wff |
2023-11-16 |
| 209068 |
PCL-PEG-Hydrazide,聚己内酯-聚乙二醇-酰肼 |
304 |
lcy |
2023-11-16 |
| 209069 |
PHA-tetra-EGOPFP 抗体偶联药物(ADC)ADC抗体 |
332 |
wff |
2023-11-16 |
| 209070 |
cas:83833-12-9 1-萘基-β-D-葡糖苷酸钠盐的参数信息 |
332 |
zyl |
2023-11-16 |
齐岳微信公众号
官方微信
库存查询